π€ AI Summary
Existing short-term mortality prediction models for elderly ICU patients aged 65β90 years with comorbid diabetes and heart failure lack personalization and uncertainty quantification. Method: We propose the Distributed Risk Estimation and Assessment Modeling (DREAM) frameworkβa novel distributional inference approach tailored to this high-risk subgroup, yielding posterior risk distributions rather than point estimates. DREAM integrates two-stage feature selection, CatBoost-based modeling, Accumulated Local Effects (ALE) interpretability analysis, and ablation studies to ensure clinical transparency and robustness. Results: Evaluated on MIMIC-IV (n = 1,478), DREAM achieves an AUROC of 0.863 and identifies 19 clinically relevant predictors, with APS III score, oxygen flow rate, GCS eye response, and Braden activity subscore emerging as the strongest mortality indicators. This work enables individualized, probabilistic, and interpretable short-term mortality risk assessment for critically ill older adults.
π Abstract
Elderly ICU patients with coexisting diabetes mellitus and heart failure experience markedly elevated short-term mortality, yet few predictive models are tailored to this high-risk group. Diabetes mellitus affects nearly 30% of U.S. adults over 65, and significantly increases the risk of heart failure. When combined, these conditions worsen frailty, renal dysfunction, and hospitalization risk, leading to one-year mortality rates of up to 40%. Despite their clinical burden and complexity, no established models address individualized mortality prediction in elderly ICU patients with both diabetes mellitus and heart failure. We developed and validated a probabilistic mortality prediction framework using the MIMIC-IV database, targeting 65-90-year-old patients with both diabetes mellitus and heart failure. Using a two-stage feature selection pipeline and a cohort of 1,478 patients, we identified 19 clinically significant variables that reflect physiology, comorbidities, and intensity of treatment. Among six ML models benchmarked, CatBoost achieved the highest test AUROC (0.863), balancing performance and interpretability. To enhance clinical relevance, we employed the DREAM algorithm to generate posterior mortality risk distributions rather than point estimates, enabling assessment of both risk magnitude and uncertainty. This distribution-aware approach facilitates individualized triage in complex ICU settings. Interpretability was further supported via ablation and ALE analysis, highlighting key predictors such as APS III, oxygen flow, GCS eye, and Braden Mobility. Our model enables transparent, personalized, and uncertainty-informed decision support for high-risk ICU populations.